Stoke Therapeutics Inc (STOK)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
8.60 +0.49 (+6.04%) 03/14/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 8.60 unch (unch) 16:03 ET
for Fri, Mar 14th, 2025
Results
download Want to compare other data? Select Fields| Symbol | STOK | KROS | EYPT | ||
| Company | Stoke Therapeutics Inc | Keros Therapeutics Inc | Eyepoint Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 8.18 | 11.56 | 6.83 | ||
| High | 8.72 | 11.77 | 7.06 | ||
| Low | 8.18 | 11.52 | 6.44 | ||
| Last | 8.60 | 11.58 | 6.52 | ||
| Change | +0.49 | +0.11 | -0.31 | ||
| % Change | +6.04% | +0.96% | -4.54% | ||
| Volume | 876,900 | 374,000 | 983,200 | ||
| 20-Day Average Volume | 750,645 | 952,745 | 809,955 | ||
| Previous Close | 8.11 | 11.47 | 6.83 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 8.41 | 11.16 | 6.49 | ||
| 20-Day Raw Stochastic | 35.48% | 66.63% | 47.34% | ||
| 20-Day Relative Strength | 44.74% | 38.33% | 45.82% | ||
| Weighted Alpha | -33.09 | -47.55 | -61.72 | ||
| Today's Opinion | 88% Sell | 88% Sell | 80% Sell | ||
| Previous Opinion | 100% Sell | 88% Sell | 80% Sell | ||
| Last Month's Opinion | 88% Sell | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.37% since 03/07/25 | +1.76% since 03/07/25 | -8.56% since 03/07/25 | ||
| Low | 7.65 on 03/11/25 | 10.62 on 03/11/25 | 6.44 on 03/14/25 | ||
| High | 8.72 on 03/14/25 | 11.94 on 03/13/25 | 7.61 on 03/12/25 | ||
| 1-Month | |||||
| %Chg | -19.48% since 02/14/25 | +12.21% since 02/14/25 | +0.31% since 02/14/25 | ||
| Low | 7.22 on 03/04/25 | 10.33 on 02/18/25 | 5.54 on 03/04/25 | ||
| High | 11.11 on 02/18/25 | 12.28 on 03/06/25 | 7.61 on 03/12/25 | ||
| 3-Month | |||||
| %Chg | -28.69% since 12/13/24 | -38.50% since 12/13/24 | -12.60% since 12/13/24 | ||
| Low | 7.22 on 03/04/25 | 9.77 on 01/15/25 | 5.54 on 03/04/25 | ||
| High | 12.98 on 02/05/25 | 19.65 on 12/16/24 | 9.50 on 01/07/25 | ||
| 6-Month | |||||
| %Chg | -40.57% since 09/13/24 | -79.68% since 09/13/24 | -28.35% since 09/13/24 | ||
| Low | 7.22 on 03/04/25 | 9.77 on 01/15/25 | 5.54 on 03/04/25 | ||
| High | 16.15 on 09/19/24 | 72.37 on 12/09/24 | 13.98 on 10/28/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 455,516 | 469,708 | 448,113 | ||
| Shares Outstanding, K | 52,967 | 40,562 | 68,729 | ||
| Annual Sales | 8,780,000 | 3,550,000 | 43,270,000 | ||
| Annual Net Income | -104,700,000 | -187,350,000 | -130,870,000 | ||
| Last Quarter Sales | 4,890,000 | 3,040,000 | 11,590,000 | ||
| Last Quarter Net Income | -26,430,000 | -46,030,000 | -41,400,000 | ||
| 60-Month Beta | 0.99 | 1.39 | 1.41 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.47 on 11/05/24 | -1.14 on 02/26/25 | -0.64 on 03/05/25 | ||
| Latest Earnings Date | 03/24/25 | 02/26/25 | 03/05/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||